Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Opinion in Pharmacology
|
May 22, 2002
Novel bone antiresorptive approaches
Michael W Lark, Ian E James
Trends in Pharmacological Sciences
|
June 1, 2014
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D Violin, Aimee L Crombie, David G Soergel, et al.
Trends in Cardiovascular Medicine
|
March 19, 2013
GPCR biased ligands as novel heart failure therapeutics
Jonathan D Violin, David G Soergel, Guido Boerrigter, et al.
Circulation. Heart Failure
|
August 15, 2012
TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure
Guido Boerrigter, David G Soergel, Jonathan D Violin, et al.
Journal of Clinical Pharmacology
|
July 2, 2013
First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers
David G Soergel, Ruth Ann Subach, Conrad L Cowan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 18, 2002
Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist
Sandra J Hoffman, Janice Vasko-Moser, William H Miller, et al.
Circulation. Heart Failure
|
August 13, 2011
Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure
Guido Boerrigter, Michael W Lark, Erin J Whalen, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers
David G Soergel, Ruth Ann Subach, Brian Sadler, et al.
Arthritis and Rheumatism
|
March 17, 2004
Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury
Michael A DiMicco, Parth Patwari, Patrick N Siparsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 31, 2010
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
Jonathan D Violin, Scott M DeWire, Dennis Yamashita, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Opinion in Pharmacology
|
May 22, 2002
Novel bone antiresorptive approaches
Michael W Lark, Ian E James
Trends in Pharmacological Sciences
|
June 1, 2014
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D Violin, Aimee L Crombie, David G Soergel, et al.
Trends in Cardiovascular Medicine
|
March 19, 2013
GPCR biased ligands as novel heart failure therapeutics
Jonathan D Violin, David G Soergel, Guido Boerrigter, et al.
Circulation. Heart Failure
|
August 15, 2012
TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure
Guido Boerrigter, David G Soergel, Jonathan D Violin, et al.
Journal of Clinical Pharmacology
|
July 2, 2013
First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers
David G Soergel, Ruth Ann Subach, Conrad L Cowan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 18, 2002
Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist
Sandra J Hoffman, Janice Vasko-Moser, William H Miller, et al.
Circulation. Heart Failure
|
August 13, 2011
Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure
Guido Boerrigter, Michael W Lark, Erin J Whalen, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers
David G Soergel, Ruth Ann Subach, Brian Sadler, et al.
Arthritis and Rheumatism
|
March 17, 2004
Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury
Michael A DiMicco, Parth Patwari, Patrick N Siparsky, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 31, 2010
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
Jonathan D Violin, Scott M DeWire, Dennis Yamashita, et al.
Page
of 2